Red light

Red Light Holland Engages Marketing Veteran and Brand Strategist, Ridley Doolittle, as Advisor to Advisory Board

Tuesday, September 14, 2021 - 1:15pm

Toronto, Ontario--(Newsfile Corp. - September 14, 2021) - Red Light Holland Corp. (CSE: TRIP) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles is pleased to announce that it has engaged Ridley Doolittle, to serve as an advisor ("Advisor") to its Advisory Board.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - September 14, 2021) - Red Light Holland Corp. (CSE: TRIP) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles is pleased to announce that it has engaged Ridley Doolittle, to serve as an advisor ("Advisor") to its Advisory Board.
  • "Ridley is someone I've personally worked with in the past when he was with Bacardi.
  • I believe he'll instantly be a tremendous asset to the Red Light Holland team as he immediately helps contribute to exploring future product offerings, marketing exposure and reach focused on increasing sales of our Red Light Holland consumer packaged goods.
  • We're pleased to have someone with his marketing know-how and work ethic," said Todd Shapiro, CEO of Red Light Holland
    "I am honoured to join this incredible team," added Ridley Doolittle.

Red Light Holland Closes Majority Stake in Acadian Exotic Mushrooms, Partnering with Leading Canadian Fresh and Dried Mushroom Producers on East Coast Facility

Tuesday, September 7, 2021 - 6:06pm

Toronto, Ontario--(Newsfile Corp. - September 7, 2021) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles, is pleased to announce that it has acquired (the "Acquisition") a 51% stake in Acadian Exotic Mushrooms Ltd. ("AEM"). AEM is a gourmet mushroom production facility co-owned by leading Canadian mushroom farming groups/individuals Holburne Mushroom Farm and Mike and Fernando Medeiros (the "Vendors") co-owners of Carleton Mushroom Farms. AEM will have the ability to produce, package and distribute a wide variety of fresh mushrooms with guaranteed sales contracts, while offering an assortment of dried options and the potential to produce functional mushroom consumer packaged goods. Start-up activities are currently underway, and the Company expects operations at AEM to commence by early 2022.

Key Points: 
  • AEM is a gourmet mushroom production facility co-owned by leading Canadian mushroom farming groups/individuals Holburne Mushroom Farm and Mike and Fernando Medeiros (the "Vendors") co-owners of Carleton Mushroom Farms.
  • "We at Red Light Holland are delighted to have inked this exciting partnership with clear industry leaders in the mushrooms sector," said Todd Shapiro, CEO and Director of Red Light Holland.
  • "This is an incredible partnership for Red Light Holland," said Bruce Linton, Chair of Red Light Holland's advisory board.
  • In connection with the Acquisition, Red Light Holland will also issue 197,318 Red Light Shares to Ed Darlington, a consultant of the Company, in satisfaction of a finder's fee.

Red Light Holland Successfully Completes Canada's Largest Legal Sale and Import of Psilocybe Truffles into Canada Under a Health Canada Approved Psilocybin Import Permit

Wednesday, September 1, 2021 - 1:11pm

This second shipment and sale from Red Light Holland to CCrest Laboratories, including three psilocybin genetics (Galindoi - Mexicana - Tampanensis), has increased logistics efficiency while again maintaining temperature-controlled refrigerated conditions from door-to-door across the Atlantic.

Key Points: 
  • This second shipment and sale from Red Light Holland to CCrest Laboratories, including three psilocybin genetics (Galindoi - Mexicana - Tampanensis), has increased logistics efficiency while again maintaining temperature-controlled refrigerated conditions from door-to-door across the Atlantic.
  • "I'm absolutely thrilled to have completed a second, even larger import and sale from the Netherlands to Canada.
  • This is just another milestone for Red Light Holland and our loyal shareholders.
  • Red Light Holland completed an initial import with CCrest in March 2021, which has yielded positive results in the first phase of the scientific research.

Red Light Closes Acquisition of Mera Life Sciences and Files Quarterly Financial Statements

Tuesday, August 31, 2021 - 1:05pm

Separately, the Company has closed its previously announced acquisition of Mera Life Sciences ("Mera").

Key Points: 
  • Separately, the Company has closed its previously announced acquisition of Mera Life Sciences ("Mera").
  • Shapiro added: "Separately, we have also completed the acquisition of Mera and its coveted psychedelic licenses in St. Vincent and the Grenadines.
  • "Working through the Mera acquisition with the various stakeholders involved has been a really fantastic experience," said William Lay, EVP and Chief Strategy Officer of Red Light Holland.
  • Upon closing of the transaction, the Company issued 700,000 Red Light Shares to the vendor of Mera.

Red Light Holland and Creso Pharma Agree to Terminate Merger

Monday, August 30, 2021 - 1:19pm

This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation.

Key Points: 
  • This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation.
  • Examples of such information include statements with respect the new supply arrangement between Red Light Holland and Creso Pharma, future acquisition opportunities and expectations for other economic, business and/or competitive factors.
  • Red Light Holland has provided forward-looking information in reliance on certain assumptions that they believe are reasonable at this time.
  • Although Red Light Holland has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended.